Beyond Air

Beyond Air, Inc. commercializes the LungFit NO‑generator platform across prenatal, infectious, and oncology markets, offering PH, PRO, and GO solutions plus Phase‑1 UNO therapy and neuro‑NOS inhibitors, positioning it as a therapeutic device company with clinical pipelines.

Headquarters: United States (USA)

Beyond Air Logo
Company Profile
  • Employees: 61
  • HQ: Garden City
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
XAIR Beyond Air
Cap: 0.0B
EQUITY NCM USD US08862L1035 Active
📈
Home Login